Skip to main content

About us
Mission & History Management Team Board of Directors Advisory Board Investors
Research & Development
Pipeline Publications
Patient resources
Alzheimer's disease
Media
News & Events
Contact
Contact form Careers

News & Events

"A l'EPFL, Asceneuron lève 30 millions" (Article in Le Matin Dimanche)

05.06.2023 - News

Read the article

Asceneuron SA

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need, including orphan tauopathies, Alzheimer’s and Parkinson’s disease.

Home
About us
Pipeline
News
Contact

Asceneuron SA

EPFL Innovation Park
Bâtiment B
1015 Lausanne
Switzerland

LinkedIn
Twitter

Geographic Coordinates

Latitude: 46.517780685612

Longitude: 6.5621010110798

Disclaimer
Credits